Caspase 3 Expressions in Children with Acute Lymphoblastic Leukemia During Induction Phase Chemotherapy
Main Article Content
Abstract
Introduction: Caspase-3 is a crucial mediator of the extrinsic apoptosis pathway. The role of caspase-3 for extrinsic apoptosis signalling is still a challenge and should be exploited in childhood ALL. This study aimed to compare the caspase-3 expression in the patient’s bone marrow before and after the induction phase of chemotherapy in childhood ALL. It will also to correlate the mean difference in caspase-3 expression between ALL standard risk and ALL high-risk patients. Methods: Seventeen newly diagnosed ALL subjects were enrolled in this study. Caspase-3 expression in bone marrow was assessed using flow cytometry and monoclonal antibodies. A T-test and a paired T-test were used to compare between groups. The correlation coefficient between ALL groups was evaluated using Spearman’s test and linear regression with a significant p-value of 0.05. Results: The caspase-3 expression is higher after induction therapy. However, it showed an insignificant difference (16.56+12.91% vs 27.71+12.33%; p = 0.08, p > 0.05). The mean difference of caspase-3 in ALL high-risk groups was significantly higher than in ALL standard-risk groups with a positive correlation (p = 0.007, r = 0.756). Conclusion: The caspase-3 expression after induction phase chemotherapy was increased in all standard-risk and high-risk patients; other lymphoblast apoptosis markers need to be confirmed alongside caspase-3
Downloads
Article Details
References
Jin M, Xu S, An Q, Wang P. A review of risk factors for childhood leukemia. Eur Rev Med Pharmacol Sci 2016; 20(18): 3760-3764.PMID: 27735044
Kaplan JA. Leukemia in Children. Pediatrics in Review 2019; 40(7):319-331. doi:10.1542/pir.2018-0192
Fernald K, Kurokawa M. Evading apoptosis in cancer. Trends in Cell Biology. Trends Cell Biol 2013; 23(12): 620-33. doi:10.1016/j.tcb.2013.07.006
Banerjee S, Uppal T, Strahan R, Dabral P, Verma SC. The modulation of apoptotic pathways by gammaherpesviruses. Front Microbiol 2016;7: 585. doi:10.3389/fmicb.2016.00585
Huang FL, Yu SJ, Li CL. Role of Autophagy and Apoptosis in Acute Lymphoblastic Leukemia. Cancer control: Journal of the Moffitt Cancer Center 2021; 28: 10732748211019138.doi:10.1177/10732748211019138
Fulda S. Tumor resistance to apoptosis. International Journal of Cancer. Int J Cancer 2009; 124(3): 511-5. doi:10.1002/ijc.24064
Malczewska M, Kośmider K, Bednarz K, Ostapińska K, Lejman M, Zawitkowska J. Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia. Cancers 2022; 14(8): 2021. doi:10.3390/cancers14082021
Chen GQ, Lu Y. Effector caspases and leukemia. International Journal of Cell Biology 2011; 2011. doi:10.1155/2011/738301
Chinnasamy S, Zameer F, Muthuchelian K. Molecular and Biological Mechanisms of Apoptosis and its Detection Techniques. Journal of Oncological Sciences 2020; 6: 49-64. doi:10.37047/jos.2020-73477
Estrov Z, Thall P, Talpaz M, Estey EH, Kantarjian H, et al. Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia. Blood 1998; 92(9): 3090-7. doi:10.1182/blood.V92.9.3090
Faderl S, Thall P, Kantarjian H, Talpaz M, Harris D, et al. Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia. Clin Cancer Res. 1999;5(12):4041-7. PMID: 10632337
Yadav P, Yadav R, Jain S, Vaidya A. Caspase-3: A primary target for natural and synthetic compounds for cancer therapy. Chem Biol Drug Des 2021; 98: 144– 165. doi:10.1111/cbdd.13860
Gamen S, Anel A, Lasierra P, Alava MA, MartinezLorenzo MJ, et al. Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way. FEBS Lett 1997; 417(3): 360-4. doi:10.1016/s0014-5793(97)01282-9
Bennett JM, Catovsky D, Daniel M ‐T, Flandrin G, Galton DAG, et al. Proposals for the classification of the acute leukemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33(4):451-8. doi:10.1111/j.1365-2141.1976.tb03563.x
Schrappe M. Prognostic Factors in Childhood Acute Lymphoblastic Leukemia. Symposium on Advances in Oncology. Indian J Pediatric 2003; 70(10): 817-24. doi:10.1007/BF02723806
Inaba H, Pui CH. Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia. J Clin Med 2021; 10(9): 1926. doi:10.3390/jcm10091926
Tebbi CK. Etiology of Acute Leukemia: A Review. Cancers 2021. 13(9): 2256. doi:10.3390/cancers13092256
Aisyi M, Dwijayanti F, Wigati R, Mahdi H, Yunus L, et al. Sepsis in children with acute lymphoblastic leukemia. Indonesian Journal of Cancer 2020; 14(4): 121–6. doi:10.33371/ijoc.v14i4.738
Kakaje A, Alhalabi MM, Ghareeb A, Karam B, Mansour B, Zahra B, Hamdan O. Rates and trends of childhood acute lymphoblastic leukaemia: an epidemiology study. Sci Rep 2020; 10: 6756. doi:10.1038/s41598-020-63528-0
Mairuhu AM, Andarsini MR, Setyoningrum RA, Cahyadi A, Larasati MCS, Ugrasena IDG, Permono B, Budiman S. Hospital acquired pneumonia risk factors in children with Acute Lymphoblastic Leukemia on chemotherapy. Heliyon 2021; 7(6): e07209. doi: 10.1016/j.heliyon.2021.e07209
Singh SK, Lupo PJ, Scheurer ME, Saxena A, Kennedy AE, et al. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine Baltimore 2016; 95(46): e5300. doi:10.1097/MD.0000000000005300
Healy J, Richer C, Bourgey M, Kritikou EA, Sinnett D. Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 2010; 95(9): 1608–1611. doi:10.3324/haematol.2010.022459
Lopes-Ramos CM, Quackenbush J, DeMeo DL. Genome-Wide Sex and Gender Differences in Cancer. Front Oncol 2020; 10: 597788. doi: 10.3389/fonc.2020.597788
Dai Q, Zhang G, Yang H, Wang Y, Ye L, et al. Clinical features and outcome of pediatric acute lymphoblastic leukemia with low peripheral blood blast cell count at diagnosis. Medicine Baltimore 2021; 100(4): e24518. doi: 10.1097/MD.0000000000024518
Al-Mulla NA, Chandra P, Khattab M, Madanat F, Vossough P, et al. Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood CancerAlliance (MECCA). Pediatric Blood Cancer 2014; 61(8): 1403-10. doi:10.1002/pbc.25031
Kiem-Hao T, Nhu Hiep P, Kim Hoa NT, Van Ha C. Causes of Death in Childhood Acute Lymphoblastic Leukemia at Hue Central Hospital for 10 Years (2008-2018). Glob Pediatr Health 2020; 7:2333794X20901930. doi: 10.1177/2333794X20901930
Khan MI, Naseem L, Manzoor R, Yasmeen N. Mortality Analysis in Children during Induction Therapy for Acute Lymphoblastic Leukemia. J Islamabad Med Dent Coll 2017; 6(2): 69-72.
Huang JS, Yang CM, Wang JS, Liou HH, Hsieh IC, Li GC, Huang SJ, Shu CW, Fu TY, Lin YC, Ger LP, Liu PF. Caspase-3 expression in tumorigenesis and prognosis of buccal mucosa squamous cell carcinoma. Oncotarget 2017; 8(48): 84237–84247.doi:10.18632/oncotarget.20494
Gebyarani I, Nugroho S, Widjajanto E. The Expression of Caspase-3 and Survivin Related with Induction Chemotherapy in Childhood Acute Lymphoblastic Leukemia. IOSR Journal of Dental and Medical Sciences 2013; 8(4): 23-29. doi: 10.9790/0853-0842329
Darzynkiewicz Z, Huang X, Okafuji M, King MA. Cytometric methods to detect apoptosis. Methods Cell Biol 2004; 75: 307-41. doi: 10.1016/S0091-679X(04)75012-8
Fortney JE, Zhao W, Wenger SL, Gibson LF. Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy. Leuk Res 2001; 25(10): 901-7. doi: 10.1016/s0145- 2126(01)00051-0
Kuttikrishnan S, Siveen KS, Prabhu KS, Khan AQ, Ahmed EI, Akhtar S, et al. Curcumin Induces Apoptotic Cell Death via Inhibition of PI3 Kinase/AKT Pathway in B-Precursor Acute Lymphoblastic Leukemia. Front Oncol 2019. doi: 10.3389/fonc.2019.00484
Xia T, Zhang J, Zhou C, Li Y, Duan W, Zhang B, Wang M, Fang J. 20(S)-Ginsenoside Rh2 displays efficacy against T-cell acute lymphoblastic leukemia through the PI3K/Akt/mTOR signal pathway. J Ginseng Res 2020; 44(5): 725–737. doi: 10.1016/j.jgr.2019.07.003
Mendivil-Perez M, Velez-Pardo C, QuirozDuque LM, RestrepoRincon A, Valencia-Zuluaga NA, et al (2022). TPEN Selectively Eliminates Lymphoblastic B cells from Bone Marrow Pediatric Acute Lymphoblastic Leukemia Patients. Biometals 2022. doi:10.20944/preprints202103.0611.v2
Gao H, Lou S, Hong H, Ge Q, Zhao H (2020). Autophagy Inhibition Potentiates the Anticancer Effects of a Bendamustine Derivative NL 101 in Acute T Lymphocytic Leukemia. BioMed Research International 2020; 2020. doi: 10.1155/2020/1520651
Fu Z, Wang L, Zhang W, Wang J, Zhu S, et al. Cytotoxic activity of lithospermum erythrorhizon root extract against childhood acute leukemia cells via regulation of PI3K/AKT/mTOR pathway. Trop J Pharm Res 2019; 18(11): 2379-2394. doi: 10.4314/tjpr.v18i11.21
Jeon SR, Lee JW, Jang PS, Chung NG, Cho B, et al (2015). Anti leukemic properties of deferasirox via apoptosis in murine leukemia cell lines. Blood Res 2015; 50(1): 33–39. doi:10.5045/br.2015.50.1.33
Lonetti A, Cappellini A, Bertaina A, Locatelli F, Pession A, et al. Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. J Hematol Oncol 2016; 9(1): 114. doi: 10.1186/s13045-016-0344-4
Salama MA, Hassab HM, Gendy W, Zeid MY. Study of Caspase-3 Level in Relation to Prognostic Risk Factors in Children with Acute Lymphoblastic Leukemia. Alex J Pediatr 2005. 9(1): 40-50. ID: emr=-69479
Cutrona G, Tasso P, Dono M, Roncella S, Ulivi M, et al. CD10 is a marker for cycling cells’ propensity to apoptosis in childhood ALL. Br J Cancer 2002; 86(11): 1776-85. doi: 10.1038/sj.bjc.6600329
Cahyadi A, Ugrasena I, Andarsini MR, Larasati M, Aryati A, Arumsari DK. Relationship between Bax and Bcl-2 Protein Expression and Outcome of Induction Phase Chemotherapy in Pediatric Acute Lymphoblastic Leukemia. Asian Pacific journal of cancer prevention 2022; 23(5): 1679–1685. doi:10.31557/APJCP.2022.23.5.1679